Literature DB >> 15889175

Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.

Ian Cumpstey1, Susanne Carlsson, Hakon Leffler, Ulf J Nilsson.   

Abstract

The galectins are a family of [small beta]-galactoside-binding proteins that have been implicated in cancer and inflammation processes. Herein, we report the synthesis of a library of 28 compounds that was tested for binding to galectins-1, -3, -7, -8N and -9N. An aromatic nucleophilic substitution reaction between 1,5-difluoro-2,4-dinitrobenzene and a galacto thiol gave 5-fluoro-2,4-dinitrophenyl 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-galactopyranoside. This versatile intermediate was then modified in a two dimensional manner: either by further substitution of the second fluoride by amines or thiols, or by reduction of the nitro groups and acylation of the resulting amines, or both. Deacetylation then gave a library of aromatic beta-galactosides that showed variable inhibitory activity against the different galectins, as shown by screening with a fluorescence-polarisation assay. Particularly efficient inhibitors were found against galectin-7, while less impressive enhancements of inhibitor affinity over methyl beta-D-galactopyranoside were found for galectin-1, -3, -8N and -9N. The best inhibitors against galectin-7 showed significantly higher affinity (K(d) as low as 140 microM) than both beta-methyl galactoside (K(d) 4.8 mM) and the unsubstituted beta-phenyl thiogalactoside (non-inhibitory). The best inhibitors against galectin-7 were poor against the other galectins and thus have potential as structurally simple and selective tools for dissecting biological functions of galectin-7.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889175     DOI: 10.1039/b502354h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  20 in total

1.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Epimers Switch Galectin-9 Domain Selectivity: 3N-Aryl Galactosides Bind the C-Terminal and Gulosides Bind the N-Terminal.

Authors:  Mukul Mahanti; Kumar Bhaskar Pal; Anders P Sundin; Hakon Leffler; Ulf J Nilsson
Journal:  ACS Med Chem Lett       Date:  2019-12-04       Impact factor: 4.345

3.  Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.

Authors:  Ruud P M Dings; Nigam Kumar; Michelle C Miller; Melissa Loren; Huzaifa Rangwala; Thomas R Hoye; Kevin H Mayo
Journal:  J Pharmacol Exp Ther       Date:  2012-12-11       Impact factor: 4.030

4.  Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.

Authors:  Fredrik R Zetterberg; Alison MacKinnon; Thomas Brimert; Lise Gravelle; Richard E Johnsson; Barbro Kahl-Knutson; Hakon Leffler; Ulf J Nilsson; Anders Pedersen; Kristoffer Peterson; James A Roper; Hans Schambye; Robert J Slack; Susan Tantawi
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

5.  Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.

Authors:  Ruud P M Dings; Michelle C Miller; Irina Nesmelova; Lucile Astorgues-Xerri; Nigam Kumar; Maria Serova; Xuimei Chen; Eric Raymond; Thomas R Hoye; Kevin H Mayo
Journal:  J Med Chem       Date:  2012-05-30       Impact factor: 7.446

Review 6.  Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways.

Authors:  Kamil Seyrek; Max Richter; Inna N Lavrik
Journal:  Cell Death Differ       Date:  2019-03-22       Impact factor: 15.828

7.  Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.

Authors:  Geoffrey Masuyer; Talat Jabeen; Christopher T Öberg; Hakon Leffler; Ulf J Nilsson; K Ravi Acharya
Journal:  FEBS J       Date:  2011-11-30       Impact factor: 5.542

8.  Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.

Authors:  Cheng-Feng Bian; Ying Zhang; Hui Sun; De-Feng Li; Da-Cheng Wang
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

Review 9.  Galectins in epithelial functions.

Authors:  Mireille Viguier; Tamara Advedissian; Delphine Delacour; Françoise Poirier; Frédérique Deshayes
Journal:  Tissue Barriers       Date:  2014-05-06

10.  Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.

Authors:  John Stegmayr; Adriana Lepur; Barbro Kahl-Knutson; Matilde Aguilar-Moncayo; Anatole A Klyosov; Robert A Field; Stina Oredsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.